A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

BACKGROUND: Novel, pragmatic, patient-centered strategies are needed to ensure fit-for-purpose patient-reported outcomes (PRO) instruments in clinical trial research for rare diseases such as myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and chronic myelomonocytic leukemia (CMML). T...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Jill A., Galaznik, Aaron, Pompilus, Farrah, Strzok, Sara, Bejar, Rafael, Scipione, Fatima, Fram, Robert J., Faller, Douglas V., Cano, Stefan, Marquis, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584583/
https://www.ncbi.nlm.nih.gov/pubmed/31218454
http://dx.doi.org/10.1186/s41687-019-0123-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584583/
https://www.ncbi.nlm.nih.gov/pubmed/31218454
http://dx.doi.org/10.1186/s41687-019-0123-4

Ejemplares similares